EUVIMEDEUVIMED entdecken
Open Access

Computational drug repurposing identifies flavoxate as a novel NLRP3 inflammasome inhibitor for Alzheimer’s disease therapy

Gajendra Choudhary, Harshita Rajput, Rutweek Kulkarni, Hadiya Siddiqui, Ajay Prakash, Bikash Medhi

In Silico Pharmacology · 31.07.2026 · 14 (2)

DOI: 10.1007/s40203-026-00696-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Silico Pharmacology, online erschienen am 31.07.2026. Verfasst von Gajendra Choudhary und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, PGIMER, Institute of Medical Education and Research, Chandigarh, India. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseAmyloid-betaDrug repurposingNLRP3-inflammasomeNeuroinflammation

Autor:innen und Institutionen

  • Department of Pharmacology, PGIMER, Institute of Medical Education and Research, Chandigarh, India.
  • Department of Biotechnology and Food Technology, Chandigarh University, Mohali, India.
  • Department of Biochemistry, PGIMER, Institute of Medical Education and Research, Chandigarh, India.

Zitieren

APA

Choudhary, G., Rajput, H., Kulkarni, R., Siddiqui, H., Prakash, A., & Medhi, B. (2026). Computational drug repurposing identifies flavoxate as a novel NLRP3 inflammasome inhibitor for Alzheimer’s disease therapy. In Silico Pharmacology, 14(2). https://doi.org/10.1007/s40203-026-00696-3

Vancouver

Choudhary G, Rajput H, Kulkarni R, Siddiqui H, Prakash A, Medhi B. Computational drug repurposing identifies flavoxate as a novel NLRP3 inflammasome inhibitor for Alzheimer’s disease therapy. In Silico Pharmacology. 2026;14(2). doi:10.1007/s40203-026-00696-3

BibTeX
@article{Choudhary2026,
  author = {Choudhary, Gajendra and Rajput, Harshita and Kulkarni, Rutweek and Siddiqui, Hadiya and Prakash, Ajay and Medhi, Bikash},
  title = {Computational drug repurposing identifies flavoxate as a novel NLRP3 inflammasome inhibitor for Alzheimer’s disease therapy},
  journal = {In Silico Pharmacology},
  year = {2026},
  volume = {14},
  number = {2},
  doi = {10.1007/s40203-026-00696-3}
}
Kostenlos starten →